Research Paper Volume 15, Issue 22 pp 12907—12926
The necroptosis signature and molecular mechanism of lung squamous cell carcinoma
Figure 12. Effect of the candidate drugs on PYGB-knockdown cells. (A) PYGB expression in the control and siPYGB groups. (B–F) Viability of the cells in response to (B) trametinib, (C) dasatinib, (D) selumetinib, (E) SCH772984 and (F) PD0325901.